we must all shift our way of thinking and bring these discussions back to our organisations to ensure that we are well poised to deal with changes in the drug development pathway, and that we ...

Rett syndrome market dynamics are expected to undergo significant shifts as more targeted therapies, including gene therapies and pharmacological interventions, enter clinical development and ...

In the barren drug development landscape, Amplia Therapeutics is making strides with its candidate that works on the anti-fibrotic path ... Read More The post Dr Boreham’s Crucible: This pancreatic ...

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

As the pharmaceutical and biotech industries continue to innovate at a rapid pace, the demand for fill/finish capabilities ...

Mutation of Lis1, a key dynein regulator, can lead to the rare mental developmental disorder lissencephaly, or “smooth brain,” where the brain’s surface lacks the normal folds and grooves, for which ...

Neurodevelopment follows a complex sequence of cellular, molecular, and behavioral milestones that shape cognitive and social functioning. In autism ...